TY - JOUR T1 - The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. JF - Invest New Drugs Y1 - 2012 A1 - Carinci, Francesco A1 - Monasta, Lorenzo A1 - Rubini, Corrado A1 - Stramazzotti, Daniela A1 - Palmieri, Annalisa A1 - Melloni, Elisabetta A1 - Knowles, Alex A1 - Ronfani, Luca A1 - Zauli, Giorgio A1 - Secchiero, Paola KW - Adult KW - Aged KW - Aged, 80 and over KW - Antineoplastic Agents KW - Apoptosis KW - Carcinoma, Squamous Cell KW - Female KW - Flow Cytometry KW - HL-60 Cells KW - Humans KW - Immunohistochemistry KW - Male KW - Middle Aged KW - Mouth Neoplasms KW - Predictive Value of Tests KW - Prognosis KW - Proportional Hazards Models KW - Recombinant Proteins KW - Risk Assessment KW - Risk Factors KW - Survival Analysis KW - TNF-Related Apoptosis-Inducing Ligand KW - Tumor Markers, Biological KW - Up-Regulation KW - Young Adult VL - 30 IS - 2 U1 - http://www.ncbi.nlm.nih.gov/pubmed/21086019?dopt=Abstract ER -